Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Redeye initiates coverage of SynAct Pharma

We initiate coverage of SynAct Pharma, a phase II biotech targeting the USD 20 billion+ rheumatoid arthritis market with its lead candidate AP1189. The SynAct team have successfully taken compounds through Phase I and II together before and has skin in the game, sitting on more than 30% of the shares. While nearer-term upside is limited by the company’s need for new capital this year, our risk-adjusted DCF model suggests a base valuation of SEK 13 per share, which comparison with peers supports as SynAct trades at a discount to other Swedish Phase II biotechs. Read more and download the

Update on US regulatory review of PT010 in COPD

This announcement contains inside information 01 October 2019 07:00 BST Update on US regulatory review of PT010 in COPD AstraZeneca today announced that the US Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for PT010 (budesonide/glycopyrronium/formoterol fumarate), an inhaled triple-combination therapy and potential new medicine for patients with chronic obstructive pulmonary disease (COPD). The NDA submitted to the FDA by AstraZeneca included data from the Phase III trial KRONOS. The Company will now work

Neste's financial reporting in 2020

Neste Corporation, Stock Exchange Release, 1 October 2019 at 9 am. (EET) Neste Corporation will publish financial reports in 2020 as follows: Financial Statements for fiscal 2019: 7 February 2020Interim Report January-March 2020: 24 April 2020Half Year Financial Report January-June 2020: 23 July 2020Interim Report January-September 2020: 22 October 2020 The Annual Report 2019 will be published on Neste's website in the week beginning on 2 March 2020. The Annual General Meeting is scheduled for Tuesday, 7 April 2020. Neste Corporation Susanna Sieppi Vice President,

Management changes at Handelsbanken

Mattias Forsberg has been appointed CIO (IT and Infrastructure). He is currently employed as CIO at SAS. He will assume his new position by February 2020, at the latest. In his new position, Mattias Forsberg will be a member of Handelsbanken’s Executive Management.   For further information, please contact:Carina Åkerström, President and Group Chief Executive, tel. +46 8–22 92 20Maria Nordin Wessman, Acting Chief Communications Officer, tel: +46 8–701 16 73Mats Olsson, Press Officer, tel: +46 8–701 35 47, +46 70–688 07 99  This information is of the type that Handelsbanken

Change of the Election Committee of Castellum AB before the AGM 2020

In accordance with the instruction for the Election Committee, the composition of the Election Committee of Castellum AB before the AGM 2020 has changed due to changes of the ownership structure in the company.The composition of the Election Committee has changed by Göran Espelund, appointed by Lannebo Fonder, replacing Hans Ek, appointed by SEB Fonder, as member of the Election Committee. After the change, the Election Committee now consists of: · Patrik Essehorn, appointed by Rutger Arnhult through companies · Vincent Fokke, appointed by Stichting Pensioenfonds ABP · Carl

Positive interactions with EMA provide route to conditional marketing authorization of lead candidate Nefecon

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that the European Medicines Agency (EMA) has provided positive guidance related to a conditional marketing authorization (CMA) of the company’s lead compound Nefecon, currently in Phase 3 clinical trials in IgA nephropathy (IgAN).In a written response received from EMA, the agency agreed that it could support CMA assessment, subject as usual to the strength of the full data set presented at the time of filing, which will also include an analysis by Calliditas related to the likelihood of achieving success in Part B of the

Proact assists Ostrava-South city district to improve data processing in-line with GDPR requirements

Proact, a leading provider of data centre solutions and cloud services, has helped Ostrava-South, the district with the largest population in the city of Ostrava, to ensure it complies with the General Data Protection Regulation (GDPR). With the goal of enhancing data protection, Proact and Ostrava-South have successfully designed and implemented a comprehensive data strategy which involves data classification, end-user visibility tools and system management.When the GDPR regulation was coming into force, the district wanted to improve the functionality of its software systems. Proact

Conversion period for Swedish Stirling KV1 initiated

Today, the conversion period begins for Swedish Stirling AB’s convertible bonds 2017/2019 (Nordic MTF: STRLNG KV1) (“KV1”). The conversion period runs from and including 1 October 2019 until and including 18 November 2019.Convertible bond holders with directly registered holdings who wish to convert its convertible bonds should request conversion by using a specific application form. Application form and information about the conversion process will be sent by regular mail to all directly registered convertible bond holders. Convertible bond holders with KV1 registered in a custody account

Primary insider subscribes shares in the Rights Issue

The following primary insider has subscribed for shares in the ongoing Rights Issue in Nordic Mining as follows: +---------+--------+-------------------+----------+------------------+|Name |Position|Number of allocated|Shares |Shares owned prior|| | |  subscription |subscribed|  to the || | |rights | |transaction |+---------+--------+-------------------+----------+------------------+|Antony H.|Board |0 |7,150 |0 ||Beckmand |member | |

Update on progress in clinical lead program VP01 (C21)

Gothenburg, October 1, 2019 – Following the successful dose escalation phase I study, Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces an update with regards to its clinical lead program VP01 (C21) and confirms progress according to plan.A phase II CTA (clinical trial application) has been filed with the MHRA, the regulatory body in the UK, for studying the effect of a single dose of C21 on cold induced vasoconstriction in subjects with systemic sclerosis (SSc). “This study will enable us to

Ivo Stopner, the President of Hufvudstaden, on sick leave until the end of the year

Ivo Stopner, the President of Hufvudstaden, will be on sick leave until the end of 2019 due to need for recovery after a period of excessive workload.The company’s Vice President Bo Wikare will assume responsibility for the duties of President until Ivo Stopner’s return on January 1, 2020. Stockholm, October 1, 2019 HUFVUDSTADEN AB (publ) Bo WikareActing President If you have any questions, please contact:Bo Wikare, Acting President, on +46 (0)8-762 90 00.

Nepa among vendors in new Analyst Report on Marketing Measurement and Optimization

STOCKHOLM, Sweden/NEW YORK, (October 1, 2019) – Nepa, a leading Consumer Science company offering customer experience and marketing optimization solutions, is among the vendors included in a just-released report from Forrester Research, Now Tech: Marketing Measurement And Optimization Solutions, Q3 2019. The report is designed to help readers understand the value of improving the business impact of marketing with measurement and optimization tools. It touches on multiple areas including determining marketing ROI and optimizing channel mix. “Forrester’s reports are highly influential

Toadman has strengthened its management team with a new COO and a new CTO

Toadman Interactive AB (publ) (“Toadman”) has added two new members to the management team, Christopher Bergstresser as Chief Operating Officer (COO) and Andreas Jonsson as Chief Technology Officer (CTO). Christopher Bergstresser has experience from executive positions at SEGA, Konami, Atari and a handful of other companies. Most recently as partner at Modern Times Group’s gaming division. Christopher will start his position today, 1 October 2019. Andreas Jonsson has experience as a senior engine developer at Fatshark, Starbreeze, Bitsquid and Autodesk. Andreas joined Toadman

Hunter Group ASA – Establishment of USD 15m Revolving Credit Facility with Apollo Asset Ltd.

Oslo, 1 October 2019 Hunter Tankers AS, a wholly owned subsidiary of Hunter Group ASA (the “Company”), has today entered into a USD 15.0 million revolving credit facility agreement (“RCF”) with Apollo Asset Ltd., a company owned by Hunter Group ASA's board member Mr. Arne Fredly.  Subsequently, the company has cancelled the outstanding USD 3.0 million RCF.  The new facility will carry a total interest rate of 5.00% p.a. all inclusive.  The facility may be cancelled at any time, by either party, whereupon the outstanding amount will become due and payable. The facility will be used to

Metsä Board has signed a bank financing facility with sustainability targets

Metsä Board Corporation Investor news 1 October 2019Metsä Board Corporation, part of Metsä Group, has signed a bank financing facility consisting of a EUR 150 million, five-year term loan and a EUR 200 million, five-year multicurrency revolving credit facility (“RCF”) with two one-year extension options and a EUR 50 million accordion option. The margin of the RCF is linked to sustainability criteria that are based on selected Metsä Board’s 2030 sustainability targets: 1. Reduction in specific water consumption 2. Reduction in specific energy consumption The new facility will be

Skanska renovates hydropower plant in the Österdal River, Sweden, for about SEK 320 M

Skanska has signed an agreement with Fortum Sweden to renovate Trängslet’s hydropower plant in Älvdalen municipality, Sweden. The contract is worth about SEK 320 M, which will be included in the Swedish order bookings for the third quarter 2019.The project includes, among other things, blasting of about 200,000 cubic meters of rock, improvement of waterways and tunnel construction in existing dams. The work will have a strong focus on minimizing the climate impact, which will characterize the choice of production methods such as mass handling, transport and collection of existing

Erika Söderberg Johnson leaves Biotage

Contact person:Torben Jörgensen, CEOTel: +46 707 49 05 84, torben.jorgensen@biotage.com  (torben.jorgensen@biotage.com) Erika Söderberg Johnson has today informed Biotage that she, after eight years of employment, is leaving the position as CFO. Erika Söderberg Johnson has a six months notice period. The company will now initiate the recruitment of a successor.  This information was submitted for publication, through the agency of the contact persons set out above, at 07:30 CET on October 1, 2019.  About BiotageBiotage offers efficient separation technologies from

Kungsleden leases out 900 sq.m in Norrköping

Kungsleden has leased approximately 900 sq.m of office space in the conveniently located property Oxelbergen 1:2 to Norrköping Municipality and FläktGroup. The building is being modernized and marketed under the office concept "Feel Good Working".The Oxelbergen property is a short walk from Norrköping city centre with both greenery and good accessibility. Kungsleden is modernizing and enhancing a vacant building of approximately 6,000 sq.m. With the concept "Feel Good Working", Kungsleden wants to create attractive and sustainable premises that inspire people and encourage an active

Kungsleden refinances debt at lower cost

Kungsleden has refinanced debt of SEK 1,7 billion by entering into a 10-year mortgage loan.The new loan, which has a maturity of 10 years replaces a previous bank loan with maturity 2021 and a mortgage loan with maturity 2036. After the refinancing, Kungsleden has no maturing bank debt before 2023. The average debt maturity decreases marginally and amounts to 4.8 years at the end of the third quarter while the borrowing cost is slightly reduced starting from 2020. In connection with the refinancing, the loan to value ratio has been increased on some pledged properties which also has

Nordic Nanovector appoints Dr Gabriele Elbl as Vice President Global Regulatory Affairs

Oslo, Norway, 1 October 2019 Nordic Nanovector ASA (OSE: NANO) announces the appointment of Dr Gabriele Elbl as Vice President Global Regulatory Affairs. Dr Elbl is a pharmacist with more than 20 years’ experience working in small and large pharmaceutical companies and at the European Medicines Agency (EMA). She brings expertise in all regulatory aspects of pharmaceutical development and submission procedures for biologicals and small molecules in Europe and in the US with focus on oncology and haematologic malignancies. Dr Elbl will join Nordic Nanovector on 1 November 2019 from

Selvaag Bolig ASA: Sold 192 homes for NOK 914 million in third quarter

Selvaag Bolig sold 192 homes worth NOK 914 million in the third quarter of 2019. Sales for the first nine months came to 739 units totalling NOK 3 633 million. “The balance between supply and demand is positive and sales have been good over the quarter. Sales of homes so far this year are more than NOK 1 billion higher than in the same period of 2018,” says CEO Rolf Thorsen. “While the market has been particularly good in Oslo and the surrounding local authorities, we have also sold well in such places as Tønsberg. We don’t expect any significant changes in market conditions during

Lundin Gold Share Capital and Voting Rights Update

VANCOUVER, BC, September 30, 2019 /CNW/ - Lundin Gold Inc. ("Lundin Gold" or the "Company") (TSX: LUG, Nasdaq Stockholm: LUG) reports the following in accordance with the Swedish Financial Instruments Trading Act:  The Company has 223,229,102 common shares issued and outstanding with voting rights as at September 30, 2019. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the Swedish Financial Instruments Trading Act on

Josemaria Share Capital and Voting Rights Update

VANCOUVER, September 30, 2019  /CNW/ - Josemaria Resources Inc. (TSX: JOSE) (OMX: JOSE) (“Josemaria Resources” or the “Company”) reports the following share capital and voting rights update in accordance with the Swedish Financial Instruments Trading Act. As a result of the issuance of common shares pursuant to the terms of previously announced credit facilities, the number of issued and outstanding shares of the Company has increased to 249,788,325 common shares with voting rights as at September 30, 2019. Additional Information This information is information that the Company is

Updated Share Capital and Voting Rights for Lundin Mining

TORONTO, ON, September 30, 2019 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) reports the following, in accordance with the Swedish Financial Instruments Trading Act: As a result of the exercise of employee stock options or the vesting of employee share units from September 1, 2019 to date, the number of issued and outstanding shares of the Company has increased to 734,540,308 common shares with voting rights as at September 30, 2019. The information in this release is subject to the disclosure requirements of Lundin Mining

There are no items matching the current filter
There are no more items matching the current filter
Back to top